Skip to main content

Effects of blood collection conditions on ovarian cancer serum markers.

Thorpe JD, Duan X, Forrest R, Lowe K, Brown L, Segal E, Nelson B, Anderson GL, McIntosh M, Urban N

Publication: PLoS One (2007) • Vol 2 • Page e1281PMID: 18060075View on PubMed

Purpose

The purpose of this paper was to determine the effects of anesthesia and time of collection with respect to day of surgery on levels of CA 125, prolactin, and Macrophage Migration Inhibitory Factor (MIF) in serum from healthy volunteers and patients with cancer and other conditions.

Conclusion

Prolactin levels were significantly increased in serum obtained after the administration of anesthesia on the day of surgery, whether from surgical control patients, benign control patients, or cancer patients, compared to levels measured in serum collected 1-39 days prior to surgery or from healthy controls, but CA-125 and MIF concentrations were only significantly affected by patient diagnosis.

Studies (1)

Purpose

The purpose of this study was to determine the effects of anesthesia and time of collection with respect to day of surgery on levels of CA 125, prolactin, and MIF in serum from healthy volunteers and patients with ovarian, fallopian tube, and peritoneal cancer and other benign and non-neoplastic conditions.

Summary of Findings

Prolactin levels were significantly increased in serum obtained after the administration of anesthesia on the day of surgery, whether from surgical control patients, benign control patients, or cancer patients, compared to levels measured in serum collected 1-39 days prior to surgery or from healthy controls. In contrast, CA 125 levels and MIF concentrations were significantly different between serum from healthy, surgical, or benign control patients and patients with cancer, regardless of whether the specimen was obtained with no anesthesia 1-39 days prior to surgery or after the administration of anesthesia on the day of surgery.

  • Biospecimens

    FluidSerum
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Not specified
    Normal
    NeoplasticBenign
    NeoplasticCarcinoma
  • Platforms

    ProteinELISA
    ProteinImmunoassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionAnesthesia
    Collected after administration of anesthesia
    Collected with no anesthesia
    PreaquisitionDiagnosis/ patient condition
    Benign condition requiring surgery
    Malignant condition requiring surgery
    Non-neoplastic condition requiring surgery
    Normal
    Biospecimen AcquisitionTime of biospecimen collection
    1-39 days prior to surgery
    On the day of surgery